London, United Kingdom

Jan Kulagowski

This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Nrg Therapeutics Ltd. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Kulagowski. Retrieved from https://idiyas.com/inventor/jan-kulagowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jan Kulagowski: Innovator in Chemical Compounds

Introduction

Jan Kulagowski is a notable inventor based in London, GB. He has made significant contributions to the field of chemical compounds, holding a total of 3 patents. His work focuses on innovative solutions that have the potential to impact various industries.

Latest Patents

Jan's latest patents include inventions related to compounds of formula (I) and acrylamide derivatives. These inventions explore new chemical formulations and their applications, showcasing his expertise in the field.

Career Highlights

Jan Kulagowski is currently associated with Nrg Therapeutics Ltd, where he continues to develop and refine his innovative ideas. His career is marked by a commitment to advancing chemical research and development.

Collaborations

Throughout his career, Jan has collaborated with talented individuals such as Tammy Ladduwahetty and Neil Miller. These partnerships have contributed to the success of his projects and the advancement of their shared goals.

Conclusion

Jan Kulagowski is a dedicated inventor whose work in chemical compounds has led to valuable patents and collaborations. His contributions continue to shape the landscape of innovation in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…